Rand Paul’s libertarian credentials took a massive hit back when he endorsed Mitt Romney in the election of 2012, but now, the Kentucky legislator is making strides for freedom once again.
Across our nation, a massive change in the way that we treat marijuana is occurring. Where the plant was formerly a victim of the “just say no” era of the misguided war on drugs, Americans have overwhelmingly embraced the drug not only for its recreational power, but, more importantly, for its medical uses. Young people are being treated with derivatives of the plant to treat seizures and other disorders to an incredibly effective end.
Now, as Attorney General Jeff Sessions has vowed to crack down on the plant’s medical legalization, Rand Paul has swooped in to bring some common sense to the table.
“U.S. Sens. Rand Paul (R-Kentucky), Corey Booker (D-New Jersey) and Kirsten Gillibrand (D-New York) introduced a bill that would end the federal prohibition of medical marijuana and take steps to improve research.
“The Compassionate Access, Research Expansion and Respect States, or CARERS, Act would effectively change the Controlled Substances Act, allowing the possession, production and distribution of medical marijuana in states with established marijuana laws.
“Twenty-nine states, as well as the District of Columbia, have already legalized marijuana, but the CARERS Act would prevent the federal government from prosecuting businesses and individuals in states where medical marijuana is legal, since federally marijuana is still illegal under the Controlled Substances Act.”
The federal government has mostly ignored the sweeping legalization of marijuana that is occurring on a state by state basis in recent years, however, Donald Trump and his Attorney General Jeff Sessions have both expressed opposition to the wholesale legalization of the drug.
Meanwhile, prescription opiates are fueling an unprecedented heroin epidemic in our nation, with overdoses on the powerful narcotic outpacing deaths from any other drug by miles. Marijuana legalization threatens the monopoly on pain management that opioid painkiller companies currently hold, creating yet another opportunity for the Big Pharmaceutical lobby to infiltrate our nations capital.